Catalyst

Slingshot members are tracking this event:

Aduro Biotech (ADRO) to launch Anti-APRIL treatment for tumor growth and immune suppression in multiple myeloma, with Phase 1 trial set to begin in 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ADRO Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 01, 2018
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Anti-april, Tumor Growth, Phase 1, Multiple Myeloma